Skip to main content
Top
Published in: Endocrine 3/2020

01-12-2020 | Editorial

Apparent Mineralocorticoid Excess: Research as an Art Form

Author: John W. Funder

Published in: Endocrine | Issue 3/2020

Login to get access

Excerpt

This issue of the Journal contains a remarkable paper from China, entitled “Apparent Mineralocorticoid Excess caused by Novel Compound Heterozygous Mutations in HSDB11 and Characterised by Early onset Hypertension and Hypokalemia”. In the very first line of the Abstract the authors begin with “Apparent Mineralocorticoid Excess is an ultra rare Autosomal Recessive Disorder…”, and continue to document their case, number 101 in the world over 30 years. For many readers of the journal, a prevalence of ~3 cases per year, often but not always the product of a consanguineous union, may be something to skip over, or to scan read at best. This would be a mistake for a series of reasons, which I will address later in this editorial review: first, however, the back story. …
Literature
1.
go back to reference M.I. New, I.S. Levine, E.G. Biglieri, J. Pariera, S. Ulick, Evidence for an unidentified steroid in a child with apparent mineralocorticold hypertension. J. Clin. Endocrinol. Metab. 44, 942–953 (1977)CrossRef M.I. New, I.S. Levine, E.G. Biglieri, J. Pariera, S. Ulick, Evidence for an unidentified steroid in a child with apparent mineralocorticold hypertension. J. Clin. Endocrinol. Metab. 44, 942–953 (1977)CrossRef
2.
go back to reference S. Ulick, L. Levine, P. Gunczalar, I.C. Ramirez, W. Rauh, A. Rosier, H.L. Bradlow, M.,I. New, A syndrome of apparent mineralocorticoid excess associated with defects in the peripheral metabolism of cortisol. J. Clin. Endocrinol. Metab. 49, 757–764 (1979)CrossRef S. Ulick, L. Levine, P. Gunczalar, I.C. Ramirez, W. Rauh, A. Rosier, H.L. Bradlow, M.,I. New, A syndrome of apparent mineralocorticoid excess associated with defects in the peripheral metabolism of cortisol. J. Clin. Endocrinol. Metab. 49, 757–764 (1979)CrossRef
3.
go back to reference J.W. Funder, P.T. Pearce, R. Smith, A.I. Smith, Mineralocorticoid action: target-tissue specificity is enzyme, not receptor, mediated. Science 242, 583–585 (1988)CrossRef J.W. Funder, P.T. Pearce, R. Smith, A.I. Smith, Mineralocorticoid action: target-tissue specificity is enzyme, not receptor, mediated. Science 242, 583–585 (1988)CrossRef
4.
go back to reference C.R.W. Edwards, P.M. Stewart, D. Burt, L. Brett, M.A. McIntyre, W.S. Sutanto, E.R. de Kloet, C. Monder, Localisation of 11 beta hydroxysteroid dehydrogenase—tissue-specific protector of the mineralocorticoid receptor. Lancet ii. 986–988 (1988) C.R.W. Edwards, P.M. Stewart, D. Burt, L. Brett, M.A. McIntyre, W.S. Sutanto, E.R. de Kloet, C. Monder, Localisation of 11 beta hydroxysteroid dehydrogenase—tissue-specific protector of the mineralocorticoid receptor. Lancet ii. 986–988 (1988)
Metadata
Title
Apparent Mineralocorticoid Excess: Research as an Art Form
Author
John W. Funder
Publication date
01-12-2020
Publisher
Springer US
Published in
Endocrine / Issue 3/2020
Print ISSN: 1355-008X
Electronic ISSN: 1559-0100
DOI
https://doi.org/10.1007/s12020-020-02488-x

Other articles of this Issue 3/2020

Endocrine 3/2020 Go to the issue
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.